Reijm, E.A.

ezh 2 cancer breast patient expression level breast cancer tumor ezh 2 levels therapy tamoxifen signi ficantly ezh 2 expression study cell numbers disease prognostic value analysis signi breast cancer res treatment bene fit response value mrna expression levels prognostic mcf 7 association mcf 7 cells upregulation protein breast cancer patients outcome number ficantly 1.00 histone siezh expression levels multivariate analysis experiment adjuvant sirna ici 164384 treatment range tamoxifen therapy estrogen er-positive survival factor specimen correlation prostate anti-estrogen status netherland table receptor rst-line effect proliferation zeste enhancer inhibition resistance polycomb model jansen methyltransferase carcinoma tertile tamoxifen treatment lysine sample prostate cancer control mirna -26a polymerase chain reaction cao q mirna